NAVIDEA BIOPHARMACEUTICALS, INC. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Mar 30, 2015
Insider Transaction Report
Form 4
LARSON BRENT L
VP Finance and CFO
Transactions
- Award
Stock Option (Right to Buy)
2015-03-26+151,000→ 151,000 totalExercise: $1.65Exp: 2025-03-26→ Common Stock (151,000 underlying)
Footnotes (1)
- [F1]Option vests 25% per year beginning on the first anniversary of the date of grant.